09.08.2017 - Martin Shkreli, the eccentric former CEO of Turing Pharmaceuticals, who made headlines in 2015 by jacking up the price of Daraprim (pyrimethamine), a 62-year-old drug used to treat...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)